<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Schizophr Bull</journal-id><journal-id journal-id-type="iso-abbrev">Schizophr Bull</journal-id><journal-id journal-id-type="publisher-id">schbul</journal-id><journal-title-group><journal-title>Schizophrenia Bulletin</journal-title></journal-title-group><issn pub-type="ppub">0586-7614</issn><issn pub-type="epub">1745-1701</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>US</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">5887596</article-id><article-id pub-id-type="doi">10.1093/schbul/sby017.578</article-id><article-id pub-id-type="publisher-id">sby017.578</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstracts</subject><subj-group subj-group-type="category-toc-heading"><subject>Poster Session II</subject></subj-group></subj-group></article-categories><title-group><article-title>F47. COGNITIVE REMEDIATION AND PHYSICAL EXERCISE IN MULTI-EPISODE SCHIZOPHRENIA: STUDY PROTOCOL FOR A RANDOMISED CONTROLLED TRIAL</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pujol</surname><given-names>Nuria</given-names></name><xref ref-type="aff" rid="AF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>P&#x000e9;rez-Sol&#x000e0;</surname><given-names>V&#x000ed;ctor</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Cortizo</surname><given-names>Romina</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Ayllon</surname><given-names>Lourdes</given-names></name><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Salvador</surname><given-names>Teresa</given-names></name><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Moreno</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Catal&#x000e0;</surname><given-names>Ferran</given-names></name><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Chamorro</surname><given-names>Jacobo</given-names></name><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Oller</surname><given-names>Silvia</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Polo-Velasco</surname><given-names>Javier</given-names></name><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Abellanas</surname><given-names>Adelina</given-names></name><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Diez-Aja</surname><given-names>Cristobal</given-names></name><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Mane</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib></contrib-group><aff id="AF0001"><label>1</label>Universitat De Barcelona</aff><aff id="AF0002"><label>2</label>Institute of Neuropsychiatry and Addiction of the Barcelona MAR Health Park, Spain Hospital del Mar Medical Research Institute, Ciber Salud Mental Group (CIBERSAM)</aff><aff id="AF0003"><label>3</label>Institute of Neuropsychiatry and Addiction of the Barcelona MAR Health Park</aff><pub-date pub-type="ppub"><month>4</month><year>2018</year></pub-date><pub-date iso-8601-date="2018-04-01" pub-type="epub"><day>01</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>4</month><year>2018</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>44</volume><issue>Suppl 1</issue><issue-title>Abstracts for the Sixth Biennial SIRS Conference</issue-title><fpage>S237</fpage><lpage>S237</lpage><permissions><copyright-statement>&#x000a9; Maryland Psychiatric Research Center 2018.</copyright-statement><copyright-year>2018</copyright-year><license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="sby017.578.pdf"/><abstract><title>Abstract</title><sec id="s1"><title>Background</title><p>Cognitive remediation (CR) and physical exercise have separately shown promising results in schizophrenia cognitive improvement, despite this, the impact on daily functionality is still limited. Physical exercise increases Brain Derived Neurotrophic Factor (BDNF) levels, promoting neuronal and cognitive plasticity, which can maximize the impact of CR. We are conducting a randomised controlled trial to determine the efficacy of an intensive program that combines CR and physical exercise on cognition and related outcomes for patients with schizophrenia. In addition, we investigate functional and structural brain effects of this intervention and its association to BDNF.</p></sec><sec id="s2"><title>Methods</title><p>This study protocol describes a randomized controlled trial in which 74 patients are randomly assigned to either CR and physical exercise or CR and health promotion. The interventions are 12-week long and consist of three weekly sessions (90min of CR and 40min of either aerobic exercise or health promotion). To be included in the study, patients must be diagnosed with schizophrenia or schizoaffective disorder, aged 28&#x02013;60 years, and do low physical activity, as measured by International Physical Activity Questionnaire, IPAQ. Exclusion Criteria for participation in the study are the presence of neurological or substance use disorders, IQ &#x0003c; 70 and somatic illnesses that contraindicate physical exercise. Healthy control participants (n=18) are screened for the presence of lifetime Axis I psychotic disorders and for the presence of a first-degree relative with schizophrenia. Primary outcome measures are cognitive performance, functional outcome, negative symptoms, BDNF levels and neuroimaging measures. Secondary outcome measures are quality of life and metabolic parameters. All measures are blindly assessed at baseline, at 3 months follow up and at 15 months follow up.</p><p>This trial was approved by the Comit&#x000e9; &#x000c8;tic d&#x02019;Investigaci&#x000f3; Cl&#x000ed;nica de l&#x02019;Hospital del Mar (CEIC) 2015/6209/I</p></sec><sec id="s3"><title>Results</title><p>This poster is a study protocol. We will correct data from now on.</p></sec><sec id="s4"><title>Discussion</title><p>The results of this trial will provide valuable information about whether cognitive remediation efficacy for patients with schizophrenia can be enhanced by aerobic exercise-induced BDNF upregulation.</p></sec><sec id="s5"><title>TRIAL REGISTRATION</title><p>The trial is registered at <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov">www.clinicaltrials.gov</ext-link> (NCT02864576)</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>